Χώρα: Κύπρος
Γλώσσα: Ελληνικά
Πηγή: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας
TELMISARTAN
DELORBIS PHARMACEUTICALS LTD (0000009620) 17 ATHINON STREET, ERGATES INDUSTRIAL AREA, LEFKOSIA, 2081, 28629
C09CA07
TELMISARTAN
80MG
TABLETS
TELMISARTAN (8000001673) 80MG
ORAL USE
Εθνική Διαδικασία
TELMISARTAN
Νομικό καθεστώς: Με Ιατρική Συνταγή που Επαναλαμβάνεται; PACK WITH 28 TABS IN BLISTER(S) (300041604) 28 TABLET - Εγκεκριμένο - Με Ιατρική Συνταγή που Επαναλαμβάνεται
COMPARATIVE TABLE ENGLISH VS GREEK PIL PACKAGE LEAFLET: INFORMATION FOR THE USER ALIMAX 40 MG TABLETS ALIMAX 80 MG TABLETS Telmisartan READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Alimax is and what it is used for 2. What you need to know before you take Alimax 3. How to take Alimax 4. Possible side effects 5. How to store Alimax 6. Contents of the pack and other information 1.WHAT ALIMAX IS AND WHAT IT IS USED FOR Alimax belongs to a class of medicines known as angiotensin II receptor ΦΎΛΛΟ ΟΔΗΓΙΏΝ ΧΡΉΣΗΣ: ΠΛΗΡΟΦΟΡΊΕΣ ΓΙΑ ΤΟΝ ΧΡΉΣΤΗ ALIMAX 40 MG ΔΙΣΚΊΑ ALIMAX 80 MG ΔΙΣΚΊΑ Τελμισαρτάνη ΔΙΑΒΆΣΤΕ ΠΡΟΣΕΚΤΙΚΆ ΟΛΌΚΛΗΡΟ ΤΟ ΦΎΛΛΟ ΟΔΗΓΙΏΝ ΧΡΉΣΗΣ ΠΡΙΝ ΑΡΧΊΣΕΤΕ ΝΑ ΠΑΊΡΝΕΤΕ ΑΥΤΌ ΤΟ ΦΆΡΜΑΚΟ, ΔΙΌΤΙ ΠΕΡΙΛΑΜΒΆΝΕΙ ΣΗΜΑΝΤΙΚΈΣ ΠΛΗΡΟΦΟΡΊΕΣ ΓΙΑ ΣΑΣ. Φυλάξτε αυτό το φύλλο οδηγιών χρήσης. Ίσως χρειαστεί να το διαβάσετε ξανά. Εάν έχετε περαιτέρω απορίες, ρωτήστε το γιατρό ή το φαρμακοποιό σας. Η συνταγή για αυτό το φάρμακο χορηγήθηκε αποκλειστικά για σας. Δεν πρέπει να δώσετε το φάρμακο σε άλλους. Μπορεί να τους προκαλέσει βλάβη, ακόμα και όταν τα συμπτώματα Διαβάστε το πλήρες έγγραφο
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Alimax 40 mg Τablets Alimax 80 mg Τablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION For 40 mg strength: Each tablet contains 40 mg telmisartan. For 80 mg strength: Each tablet contains 80 mg telmisartan. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablets For 40 mg strength: White to off-white, oblong tablet, with a break line on one side. For 80 mg strength: White to off-white, oblong tablet, embossed with the letter ‘’D’’ and with a break line on one side. The tablets can be divided into equal doses. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS _Hypertension_ Treatment of essential hypertension in adults (see sections 4.3, 4.4, 4.5 and 5.1). 1 _Cardiovascular prevention_ Reduction of cardiovascular morbidity in adults with (see sections 4.3, 4.4, 4.5 and 5.1): Manifest atherothrombotic cardiovascular disease (history of coronary heart disease, stroke, or peripheral arterial disease) or Type 2 diabetes mellitus with documented target organ damage 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Treatment of essential hypertension:_ The usually effective dose is 40 mg once daily. Some patients may already benefit at a daily dose of 20 mg. In cases where the target blood pressure is not achieved, the dose of telmisartan can be increased to a maximum of 80 mg once daily. Alternatively, telmisartan may be used in combination with thiazide-type diuretics such as hydrochlorothiazide, which has been shown to have an additive blood pressure lowering effect with telmisartan (see sections 4.3, 4.4, 4.5 and 5.1). When considering raising the dose, it must be borne in mind that the maximum antihypertensive effect is generally attained four to eight weeks after the start of treatment (see section 5.1). _Cardiovascular prevention:_ The recommended dose is 80 mg once daily. It is not known whether doses lower than 80 mg of telmisartan are effective in reducing cardiovascular morbidity. When initiating te Διαβάστε το πλήρες έγγραφο